Skip to main content
Metformin

Can You Take Metformin If You Have Kidney Problems?

Julie Adkison, PharmD, BCACP, CDCESKatie E. Golden, MD
Written by Julie Adkison, PharmD, BCACP, CDCES | Reviewed by Katie E. Golden, MD
Updated on November 6, 2026

Key takeaways:

  • Metformin doesn’t damage your kidneys, but having kidney problems may raise your risk of a specific side effect called lactic acidosis.

  • If you have chronic kidney disease (CKD), it usually just means you may need to take a lower dosage or monitor your kidney function while taking it.

  • In people with diabetes, metformin helps keep your blood sugar (blood glucose) levels within a healthy range. Over time, this may lower the risk of diabetes-related kidney damage.

Save on related medications

One of the most popular diabetes medications is metformin. It’s an effective treatment to lower hemoglobin A1C — known as A1C, a measure of your average blood glucose over the past several months — while also offering some other benefits.

Questions often come up about metformin and its effect on the kidneys — especially because many people with diabetes also have chronic kidney disease (CKD). So, can you take metformin if you already have kidney problems? And will metformin hurt your kidneys if they are healthy?

There’s a lot of misinformation out there. So let’s clear up the confusion and go over what you should know about taking metformin safely.

What is metformin?

Metformin is often the first-choice oral medication for Type 2 diabetes. It’s also prescribed off-label for:

Metformin works in a few ways to improve blood sugar and insulin resistance. It helps:

  • Lower the amount of glucose made by the liver

  • Improve your body’s response to insulin

  • Lower the amount of glucose you absorb from food

On its own, metformin is available as immediate-release (IR) and extended-release (ER) tablets and an oral solution. It’s also available in several different combination pills with other diabetes medications. 

Metformin dosages vary from person to person. But you’ll typically take metformin once or twice a day. Larger dosages may be divided into 3 daily doses. The maximum dosage of metformin is usually 2,000 mg to 2,550 mg per day. 

Your dosage will likely be lower if you have kidney problems, which we cover in more detail later in this article.

Does metformin harm your kidneys?

No, metformin hasn’t been shown to cause kidney problems or make them worse. The kidneys help clear metformin from your body after it has done its job, but they aren’t harmed in the process. Your kidneys must be working normally to effectively get rid of metformin though.

Can you take metformin if you have kidney problems?

Yes, people with kidney problems can take metformin. But the dosage may need to be adjusted in accordance with your kidney function. And people with severe or advanced CKD may need to balance the risks and benefits of taking metformin with their healthcare team.

If you have kidney problems, metformin can lead to a rare but possible risk of something called lactic acidosis. This can happen when the kidneys aren’t able to clear metformin from the body, which leads to a buildup of lactic acid in the blood. Severe cases of lactic acid significantly alter the pH in the body, which can be life-threatening without treatment. But again, these cases are very rare — even in people with more advanced stages of kidney disease.

To know your risk of this side effect if you have kidney problems, it helps to know your stage of kidney disease. 

Kidney function is measured by something called the estimated glomerular filtration rate (eGFR). This is a laboratory estimate of how well your kidneys are filtering your blood. A lower eGFR means a more decreased kidney function. Experts recommend adjusting your metformin dosage based on this number. The result is measured in mL/min/1.73m². But you can just pay attention to the number itself: 

  • eGFR 60 or higher: Safe for standard dosage with monitoring of kidney function every year

  • eGFR 45 to 59: Safe for standard dosage with monitoring of kidney function every 3 to 6 months

  • eGFR 30 to 44: Decreased dosage with monitoring of kidney function every 3 months

  • eGFR below 30: Metformin shouldn’t be used (the medical term is “contraindicated”)

Currently, the guidelines recommend you not take metformin if your eGFR drops below 30 — or if you start dialysis. But it’s important to note that kidney specialists are starting to rethink and challenge this guideline. Even in people with an eGFR less than 30, research suggests that continued metformin treatment still leads to significant health benefits with a low risk of lactic acidosis. So, if you’re in this group, you should have a risks versus benefits discussion with your healthcare team to know if metformin is a good choice for you.

Does metformin help the kidneys?

Yes, metformin helps protect the kidneys from damage from diabetes.

Up to 40% of people living with Type 2 diabetes eventually develop kidney failure. One of the best ways to prevent this from happening is by keeping blood glucose in check. So, for people with diabetes, metformin plays an important role in keeping their kidneys healthy.

If you have CKD, there’s some evidence that: 

But other medications have stronger evidence for protecting the kidneys — such as sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists.

Frequently asked questions

No, metformin isn’t known to affect other organs. But there are some long-term side effects that you should be aware of. These include low vitamin B12 levels, which can lead to anemia (low blood count) and worsened nerve damage.

In addition to kidney disease, other health conditions can put you at higher risk of lactic acidosis. These include:

Yes, metformin is safe for most people. Most commonly, you may experience temporary stomach-related side effects when first starting treatment. This includes diarrhea, nausea, and vomiting. For many people, these improve within the first few weeks.

Metformin is also a safer treatment option if you’re at risk for experiencing low blood glucose (hypoglycemia). Because of how it works, hypoglycemia is less likely to happen with metformin compared to many other diabetes medications. 

Metformin is one of the safest medications for people with diabetes because it’s unlikely to cause dangerous episodes of hypoglycemia. But if you can’t take metformin, there are many alternative medications. Some examples include:

  • Glucagon-like peptide-1 (GLP-1) agonists like Ozempic (semaglutide) and Trulicity (dulaglutide)

  • Mounjaro (tirzepatide), which is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 agonist 

  • Sodium-glucose cotransporter-2 (SGLT2) inhibitors, like Farxiga (dapagliflozin) and Jardiance (empagliflozin)

  • Insulin, which may be a good option for people whose diabetes is progressing or who can’t tolerate common oral medications

There are other alternatives to metformin such as sulfonylureas and gliptins. But these aren’t first-choice medications for various reasons — such as risk for hypoglycemia or weight gain.

Metformin can be taken long term. For many people, it’s a lifelong medication. If you have kidney disease, your healthcare team will monitor your kidney function to make sure it continues to be a safe choice for you.

No, metformin doesn’t cause kidney stones or increase your risk of kidney stones.

The bottom line

Metformin is often a first-choice treatment for Type 2 diabetes. It’s not known to be harmful to your kidneys or other organs. But if you have kidney problems, there’s a greater risk of a serious condition called lactic acidosis.

Your healthcare team should watch your kidney function while you’re taking metformin. Depending on your estimated glomerular filtration rate (eGFR), you may need to take a lower dosage. And in some cases, you may need to stop taking metformin.

why trust our exports reliability shield

Why trust our experts?

Julie Adkison, PharmD, BCACP, CDCES, is a clinical pharmacist specializing in ambulatory care practice and diabetes care and education. She has worked in a faculty position in family medicine for many years.
Katie E. Golden, MD, is a board-certified emergency medicine physician and a medical editor at GoodRx.

References

American Diabetes Association Professional Practice Committee for Diabetes, et al. (2026). Pharmacologic approaches to glycemic treatment: Standards of care in diabetes—2026. Diabetes Care. 

Charytan, D. M., et al. (2019). Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease. Diabetes, Obesity & Metabolism.

DailyMed. (2026). Metformin METFORMIN ER 500 MG tablet.

Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. (2022). KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease.

Kwon, S., et al. (2020). The long-term effects of metformin on patients with type 2 diabetic kidney disease. Diabetes Care.

National Kidney Foundation. (n.d.). Diabetes - a major risk factor for kidney disease.

National Kidney Foundation. (2026). Estimated glomerular filtration rate (eGFR).

Orloff, J., et al. (2021). Safety and effectiveness of metformin in patients with reduced renal function: A systematic review. Diabetes, Obesity & Metabolism.

Out, M., et al. (2018). Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3 year trial. Journal of Diabetes and its Complications.

Rosen, D. C., et al. (2022). Is metformin use associated with changes in urinary parameters in stone formers? Canadian Urological Association Journal.

Shin, J., et al. (2024). Metformin in people with diabetes and advanced CKD: Should we dare? American Journal of Kidney Diseases.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Latest articles